BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 36324143)

  • 21. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
    Gurka MJ; Guo Y; Filipp SL; DeBoer MD
    Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome.
    Lyerly GW; Sui X; Church TS; Lavie CJ; Hand GA; Blair SN
    Mayo Clin Proc; 2010 Mar; 85(3):239-46. PubMed ID: 20160139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study.
    Hadaegh F; Mohebi R; Cheraghi L; Tohidi M; Moghaddam NB; Bozorogmanesh M; Sheikholeslami F; Azizi F
    Stroke; 2012 Jun; 43(6):1669-71. PubMed ID: 22382161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High normotension is associated with future metabolic syndrome but not cardiovascular disease: A 10-year longitudinal study.
    Chen YL; Hsu CH; Hsieh CH; Wu CZ; Lin JD; Chang JB; Liang YJ; Tsai YT; Hsia TL; Pei D
    Medicine (Baltimore); 2017 Jun; 96(25):e7227. PubMed ID: 28640118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.
    Chee Cheong K; Lim KH; Ghazali SM; Teh CH; Cheah YK; Baharudin A; Lim HL; Abdul Hamid AM; Mustapha FI; Omar MA
    BMJ Open; 2021 Aug; 11(8):e047849. PubMed ID: 34408040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
    Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
    J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.
    Hwang IC; Kim KK; Jee SH; Kang HC
    Yonsei Med J; 2011 Mar; 52(2):220-6. PubMed ID: 21319338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study.
    He D; Zhang X; Chen S; Dai C; Wu Q; Zhou Y; Jin Z; Wu S; Zhu Y
    Front Cardiovasc Med; 2021; 8():706999. PubMed ID: 34422932
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging.
    Maggi S; Noale M; Gallina P; Bianchi D; Marzari C; Limongi F; Crepaldi G;
    J Gerontol A Biol Sci Med Sci; 2006 May; 61(5):505-10. PubMed ID: 16720749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
    Kodama S; Saito K; Tanaka S; Maki M; Yachi Y; Asumi M; Sugawara A; Totsuka K; Shimano H; Ohashi Y; Yamada N; Sone H
    JAMA; 2009 May; 301(19):2024-35. PubMed ID: 19454641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome in Russian adults: associated factors and mortality from cardiovascular diseases and all causes.
    Sidorenkov O; Nilssen O; Grjibovski AM
    BMC Public Health; 2010 Sep; 10():582. PubMed ID: 20920226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
    Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
    Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.
    Mirbolouk M; Asgari S; Sheikholeslami F; Mirbolouk F; Azizi F; Hadaegh F
    Geriatr Gerontol Int; 2015 Apr; 15(4):449-56. PubMed ID: 24750352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender discrepancy in the predictive effect of metabolic syndrome and its components on newly onset cardiovascular disease in elderly from rural China.
    Yu S; Guo X; Li G; Yang H; Zheng L; Sun Y
    BMC Geriatr; 2021 Sep; 21(1):505. PubMed ID: 34563137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese.
    Yamazaki Y; Fujihara K; Sato T; Harada Yamada M; Yaguchi Y; Matsubayashi Y; Yamada T; Kodama S; Kato K; Shimano H; Sone H
    J Atheroscler Thromb; 2024 Apr; 31(4):382-395. PubMed ID: 37981330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults.
    Sun DL; Wang JH; Jiang B; Li LS; Li LS; Wu L; Wu HY; He Y
    J Geriatr Cardiol; 2012 Jun; 9(2):123-9. PubMed ID: 22916057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.